Paul Averback - Net Worth and Insider Trading
Paul Averback Net Worth
The estimated net worth of Paul Averback is at least $5 Million dollars as of 2024-09-20. Paul Averback is the CEO, 10% Owner of Nymox Pharmaceutical Corp and owns about 21,643,948 shares of Nymox Pharmaceutical Corp (NYMXF) stock worth over $5 Million. Details can be seen in Paul Averback's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Paul Averback has not made any transactions after 2018-10-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Paul Averback
Paul Averback Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Paul Averback owns 1 companies in total, including Nymox Pharmaceutical Corp (NYMXF) .
Click here to see the complete history of Paul Averback’s form 4 insider trades.
Insider Ownership Summary of Paul Averback
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NYMXF | Nymox Pharmaceutical Corp | 2018-10-29 | director & 10 percent owner & CEO |
Paul Averback Latest Holdings Summary
Paul Averback currently owns a total of 1 stock. Paul Averback owns 21,643,948 shares of Nymox Pharmaceutical Corp (NYMXF) as of October 29, 2018, with a value of $5 Million.
Latest Holdings of Paul Averback
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NYMXF | Nymox Pharmaceutical Corp | 2018-10-29 | 21,643,948 | 0.22 | 4,735,696 |
Holding Weightings of Paul Averback
Paul Averback Form 4 Trading Tracker
According to the SEC Form 4 filings, Paul Averback has made a total of 0 transactions in Nymox Pharmaceutical Corp (NYMXF) over the past 5 years. The most-recent trade in Nymox Pharmaceutical Corp is the sale of 1,687,600 shares on October 29, 2018, which brought Paul Averback around $4 Million.
Insider Trading History of Paul Averback
- 1
Paul Averback Trading Performance
Paul Averback Ownership Network
Paul Averback Owned Company Details
What does Nymox Pharmaceutical Corp do?
Who are the key executives at Nymox Pharmaceutical Corp?
Paul Averback is the director & 10 percent owner & CEO of Nymox Pharmaceutical Corp. Other key executives at Nymox Pharmaceutical Corp include Chief Financial Officer Erik Danielsen , and director & General Counsel Randall J Lanham .
Nymox Pharmaceutical Corp (NYMXF) Insider Trades Summary
Over the past 18 months, Paul Averback made no insider transaction in Nymox Pharmaceutical Corp (NYMXF). Other recent insider transactions involving Nymox Pharmaceutical Corp (NYMXF) include a net purchase of 120,000 shares made by James George Robinson ,
In summary, during the past 3 months, insiders sold 0 shares of Nymox Pharmaceutical Corp (NYMXF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nymox Pharmaceutical Corp (NYMXF) were sold and 120,000 shares were bought by its insiders, resulting in a net purchase of 120,000 shares.
Nymox Pharmaceutical Corp (NYMXF)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nymox Pharmaceutical Corp Insider Transactions
Paul Averback Mailing Address
Above is the net worth, insider trading, and ownership report for Paul Averback. You might contact Paul Averback via mailing address: C/o Nymox Pharmaceutical Corporation, 9900 Cavendish Blvd., Suite 306, St. Laurent A8 H4m 2v2.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
